Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Q1 2022 Thoughts
View:
Post by swyint123888 on May 03, 2022 7:55am

Q1 2022 Thoughts

Q4 2021 AI revs - 2,700,000
Q1 2022 AI revs - 3,750,000

Q4 total revs 2020 - 4,750,000
Q4 total revs 2021 - 8,729,000

Q4 2021 total revs break down as such 8,729,000 total - 2,700,000 AI = 6,029,000 covid revs for Q4 2021 with only 14,202 test done in Dec, we don't know Oct or Nov

Jan Feb and Mar came in at 19,446,23,655 and 25,333.....if priced the same in Q1 as Q4 our Q1 2022 revs may be higher than my revised lower number of 10 - 12 million.....much more testing done than Dec for sure.....19 million from 2021 could be attainable.....hopefully Q1 2022 has some NDA and auto renewal revs, Q4 had none so good odds Q1 2022 might have some.

Anyways another decent report in the next month and the uplist, be nice to uplisted with analyst coverage and a strong buy rating
Comment by Investor10X on May 03, 2022 10:09am
I don't think anyone here is under any illusion in believing that Q1 2022 will be higher than Q1 2021. It won't.  Q1 2021 were incredible numbers, yet they never got priced into the stock because the view was it was nearly all covid money and little AI.  So by those standards, even with less revenue the reaction should be better because we know the AI and Tech will be higher ...more  
Comment by SeniorC on May 03, 2022 10:55am
My reading of the situation is about the same. AI rev (what really makes the difference on the SP) should be the best Qx AI revenues for DM.  COVID testing was never accounted in the SP but it will eventually help DP to reach the top of the ratios in the industry as it act like a stabilization mode for at least 22-23 which is enough for the other verticals to have an impact on the SP. let ...more  
Comment by astutein on May 03, 2022 11:06am
investorx the projection and analysis man. Questions for you to answer? From the facts below Q4 showed no profit on revenue of 8.714million  .  Net profit dropped by 0.006 cents. . Questions  1. What is so good abou Q4 Revenue and produces small loss.?                    2. What is your profit projection for Q1 with ...more  
Comment by swyint123888 on May 03, 2022 11:23am
The only let down in the year was Q4 really....cash and cash equivilents dropped to 15 mill from 20......just under 9 million in revs and about a million dollar loss....hope this high burn rate is seasonal and not an indication of "cost" issues.....this being said it's 4 months backwards looking....Q1 will be the most recent fresh meat to absorb.
Comment by Shlinker_ on May 03, 2022 11:41am
Wait until they sell Medicall to SCRN for shares, a failing company, but I'm just a basher.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities